Sign in
4

Changes in Ownership

MapLight Therapeutics, Inc. Filed Acc 0002021233-26-000012

Chief Medical Officer sold 47,158 shares at an average $36.78 ($1,734,490)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Foff Erin Pennock · Chief Medical Officer

Table I: Non-derivative

9 lines
Date Transaction Shares Price Value Owned after D/I
2026-07-15 Sale : show line 1 in the form 10b5-1 −7,155 $36.16 $258,725 338,904 D
2026-07-15 Sale : show line 2 in the form 10b5-1 −7,845 $37.04 $290,579 331,059 D
2026-07-15 Sale : show line 3 in the form 10b5-1 −4,465 $36.00 $160,740 326,594 D
2026-07-15 Sale : show line 4 in the form 10b5-1 −8,972 $36.99 $331,874 317,622 D
2026-07-15 Sale : show line 5 in the form 10b5-1 −18 $37.54 $676 317,604 D
2026-07-16 Sale : show line 6 in the form 10b5-1 −9,163 $36.46 $334,083 308,441 D
2026-07-16 Sale : show line 7 in the form 10b5-1 −5,865 $37.26 $218,530 302,576 D
2026-07-16 Sale : show line 8 in the form 10b5-1 −19 $37.96 $721 302,557 D
2026-07-17 Sale : show line 9 in the form 10b5-1 −3,656 $37.90 $138,562 298,901 D
Open-market sales · 47,158 sh · avg $36.78 · $1,734,490
Loading xslF345X06/form4-07182026_010714.xml…